MedPath

Evaluation of the effect of cloves in the treatment of depressio

Phase 2
Conditions
Major depressive disorder.
Major depressive disorder, single episode
Registration Number
IRCT20220426054668N1
Lead Sponsor
Artesh University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
62
Inclusion Criteria

A score of 19 or higher on the 17-item HAM-D Scoring Tool and a score of 2 or higher on the first HAM-D item

Exclusion Criteria

Received any type of antidepressant in the past months
Received electroshock during the last 2 months
Having evidence in favor of psychosis or other mental illnesses
Suicidal thoughts (score higher than 2 on HAM-D suicide item)
Addiction or abuse of alcohol or other substances (excluding nicotine)
Uncontrollable physical diseases such as thyroid, heart and liver diseases
Patient dissatisfaction with participation in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression score on the Hamilton questionnaire. Timepoint: Before the study, two, four and six weeks after starting treatment. Method of measurement: Hamilton Depression Inventory.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath